Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03985449 · ClinicalTrials.gov registry record · NA
Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings
A NA study of Uterine Fibroid, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 748
- Enrollment target
- 1
- Study location
NCT03985449 is a NA study of Uterine Fibroid that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 748 participants, above the 172-participant average among 5 other Uterine Fibroid trials with a reported enrollment target (335% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03985449, a NA study of Uterine Fibroid, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 748 participants
- Enrollment target
- 1
- Study location
Study Summary
UPFRONT is a study that aims to use two implementation frameworks - the Consolidated Framework for Implementation Research and the Normalization Process Theory - to guide the implementation of a uterine fibroid patient decision aid, known as Option Grid, at five diverse gynecology settings across the United States. Option Grid provides evidence-based information on the various treatment options to help women across socioeconomic strata with symptomatic uterine fibroids make a preference-sensitive decision.
Conditions Studied
Interventions
- OTHER Uterine Fibroid Option Grid encounter patient decision aid (text only)
- OTHER Uterine Fibroid Option Grid encounter patient decision aid (text + Pictures)
- OTHER Uterine Fibroid Option Grid encounter patient decision aid (online)
Study Locations (1)
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 748 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2023-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03985449
The ClinicalTrials.gov registry entry for NCT03985449 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 748 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 172-participant average among 5 other Uterine Fibroid trials with a reported enrollment target (335% higher). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uterine Fibroid appearing as the primary indexed condition, and to 3 interventions - of which Uterine Fibroid Option Grid encounter patient decision aid (text only) is the first listed.
NCT03985449 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.
Frequently Asked Questions
What is clinical trial NCT03985449 about?
NCT03985449 is a clinical study titled "Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings". UPFRONT is a study that aims to use two implementation frameworks - the Consolidated Framework for Implementation Research and the Normalization Process Theory - to guide the implementation of a uterine fibroid patient decision aid, known as Option Grid, at five diverse gynecology settings across th...
What is the current status of trial NCT03985449?
This trial is currently completed. It is a NA study. The enrollment target is 748 participants. The study started on 2019-08-01. Estimated completion is 2023-01-15.
What conditions does trial NCT03985449 study?
This clinical trial studies the following conditions: Uterine Fibroid.
What interventions are being tested in trial NCT03985449?
The interventions under investigation include: Uterine Fibroid Option Grid encounter patient decision aid (text only) (OTHER), Uterine Fibroid Option Grid encounter patient decision aid (text + Pictures) (OTHER), Uterine Fibroid Option Grid encounter patient decision aid (online) (OTHER).
Who is sponsoring clinical trial NCT03985449?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03985449 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Fibroid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Life Study: Lifestyle Intervention in Fibroid Elimination
ACTIVE NOT RECRUITING · NA
-
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
RECRUITING
-
Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE
RECRUITING · Phase 2
-
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
COMPLETED · Phase 3
-
An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.